or Try an Advanced Search...

    Technical Analysis for PSTX - Poseida Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 2.71 -7.19% -0.21
    PSTX closed down 7.19 percent on Wednesday, May 8, 2024, on 47 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Flat Down Up
    Historical PSTX trend table...
    Date Alert Name Type % Chg
    200 DMA Support Bullish 0.00%
    Earnings Movers Other 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Calm After Storm Range Contraction -7.19%
    NR7 Range Contraction -7.19%
    Earnings Movers Other -7.19%
    Wide Bands Range Expansion -7.19%
    Overbought Stochastic Strength -7.19%
    50 DMA Resistance Bearish -4.24%
    Older End-of-Day Signals for PSTX ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 9 hours ago
    200 DMA Support about 9 hours ago
    Fell Below 200 DMA about 10 hours ago
    60 Minute Opening Range Breakdown about 13 hours ago
    Down 5% about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PSTX Chart by TradingView
    Basic chart:

    Profile

    Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis

    Is PSTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 3 Broker Revenue Forecasts For Poseida Therapeutics, Inc. (NASDAQ:PSTX) Are Surging Higher
    May 2 Xyphos and Poseida to develop allogeneic cell therapies for cancer
    May 1 Poseida gains on cell therapy pact with Astellas
    May 1 Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
    May 1 Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
    Apr 18 Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
    Apr 17 Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
    Apr 8 Poseida Therapeutics files to sell 8.33M shares of common stock by holders
    Apr 8 Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma
    Mar 26 Poseida Therapeutics appoints Syed Rizvi as Chief Medical Officer
    See more PSTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.27
    52 Week Low 1.54
    Average Volume 758,733
    200-Day Moving Average 2.71
    50-Day Moving Average 2.92
    20-Day Moving Average 2.42
    10-Day Moving Average 2.58
    Average True Range 0.23
    RSI (14) 52.15
    ADX 26.66
    +DI 26.71
    -DI 21.61
    Chandelier Exit (Long, 3 ATRs) 2.33
    Chandelier Exit (Short, 3 ATRs) 2.56
    Upper Bollinger Bands 3.11
    Lower Bollinger Band 1.72
    Percent B (%b) 0.71
    BandWidth 57.61
    MACD Line -0.01
    MACD Signal Line -0.12
    MACD Histogram 0.1028
    Fundamentals Value
    Market Cap 259.14 Million
    Num Shares 95.6 Million
    EPS -1.54
    Price-to-Earnings (P/E) Ratio -1.76
    Price-to-Sales 6.92
    Price-to-Book 2.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.06
    Resistance 3 (R3) 3.08 3.00 3.00
    Resistance 2 (R2) 3.00 2.91 2.98 2.98
    Resistance 1 (R1) 2.85 2.85 2.81 2.83 2.96
    Pivot Point 2.77 2.77 2.75 2.75 2.77
    Support 1 (S1) 2.62 2.68 2.58 2.60 2.46
    Support 2 (S2) 2.54 2.62 2.52 2.44
    Support 3 (S3) 2.39 2.54 2.42
    Support 4 (S4) 2.37